Loading
Liver Disease Diagnosis and Treatment / Adipokines, Inflammation, and Metabolic Diseases · Journal article
Frontiers in Immunology · September 3, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a descriptive immunohistochemical study of paired liver biopsies before and after bariatric surgery in patients with severe obesity and liver disease. The authors document shifts in immune cell populations post-operatively (increased CD15+ neutrophils, CD56+ NK cells, CD68+/CD163+ macrophages, and CD4+ T cells) despite histological and metabolic improvement, suggesting a persistent altered immune state rather than normalization; however, the study lacks sample-size justification, statistical significance testing, and a healthy control comparator, limiting inference about causality or clinical relevance.
Observational cohort study with paired biopsy analysis. Patients with severe obesity: (1) with liver damage before bariatric surgery; (2) paired follow-up post-surgery; (3) without evaluable liver injury per NASH CRN criteria.. Intervention: Bariatric surgery. Compared with: Pre-operative state and patients without liver injury.
Post-bariatric surgery, significant reduction in BMI and improvements in liver histology observed, but lobular inflammation persisted at median 6-year follow-up CD15+ neutrophils notably increased postoperatively CD56+ natural killer cells progressively accumulated across healthy, pre-surgical, and post-surgical cohorts
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
While the observation of persistent immune activation despite metabolic and histological improvements is intriguing, the lack of quantitative comparisons, statistical testing, and sample-size justification means the findings should be interpreted as hypothesis-generating rather than definitive. Clinicians should await confirmatory studies with adequate power and controlled comparisons before considering immune profiling for post-surgical management.
Descriptive immunohistochemical analysis of liver biopsies in a small observational cohort with paired pre- and post-surgical samples; identifies immune cell patterns but lacks a control group, quantitative endpoints, or statistical testing to support causal claims.
As stated by the source record.
Quoted from the source exactly as published.
While the observation of persistent immune activation despite metabolic and histological improvements is intriguing, the lack of quantitative comparisons, statistical testing, and sample-size justification means the findings should be interpreted as hypothesis-generating rather than definitive. Clinicians should await confirmatory studies with adequate power and controlled comparisons before considering immune profiling for post-surgical management.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
Severe obesity is linked to metabolic dysfunction-associated steatotic liver disease (MASLD), which can progress to metabolic dysfunction-associated steatohepatitis (MASH) and advanced fibrosis. Currently, there are no accurate tissue biomarkers for measuring immune-mediated liver injury or remission post-bariatric surgery. This study utilized digital pathology and immunohistochemistry to analyze liver biopsies from three patient groups: those with severe obesity and liver damage before bariatric surgery, their paired re-do biopsies post-surgery, and patients with severe obesity and without evaluable liver injury per NASH CRN criteria. Quantitative metrics assessed immune cell proportions and staining areas from whole-slide images. Following bariatric surgery, patients experienced a significant reduction in body mass index (BMI) and improvements in liver histology, although lobular inflammation persisted at a median follow-up of six years. Analysis of the innate immune response showed a notable increase in CD15 + neutrophils postoperatively, along with a progressive accumulation of CD56 + natural killer cells across healthy and pre- and post-surgical cohorts. Additionally, long-term post-surgical samples exhibited higher densities of CD68 + and CD163 + macrophages. Within the adaptive immune compartment, the number of CD4 + T cells significantly increased after surgery, while the abundance of CD8 + T cells remained stable across all groups. Overall, the livers of postsurgical patients displayed the highest burden of immune cells and a restructured hierarchy of immune populations. This indicates the presence of a unique immune microenvironment associated with surgery rather than a return to a “healthy liver” profile. Despite metabolic and histological improvements post-surgery, persistent immune activation suggests a unique immunological state where immune cells may play dual roles in both liver damage and repair, emphasizing the need for comprehensive immune profiling and targeted therapeutic strategies.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.